Founded in Paris in 1920, Gide is a leading international law firm with 12 offices spread throughout the world.
Gide is physically present in six regions of the world, with 11 offices, enabling it to act on cases globally.
23 August 2024
Deals | Poland | M&A
Our International office Gide Warsaw has advised Polish Enterprise Fund VII, a private equity fund managed by Enterprise Investors, on the sale of Nu-Med, a leading Polish company specialising in radiotherapy treatment for cancer patients, to Affidea a pan-European provider of specialist healthcare services, including cancer care, advanced diagnostic imaging and community-based polyclinics. The deal is subject to approval by the Polish Office of Competition and Consumer Protection.
The team from Gide Warsaw, comprising Paweł Grześkowiak (advocate, partner), Wojciech Czyżewski (advocate, counsel) and Magdalena Zawiślak (trainee attorney-at-law, associate), provided comprehensive support to the fund in connection with the transaction, including on a due diligence investigation, preparing and negotiating the share purchase agreement, as well as with the W&I policy.
Enterprise Investors is one of the largest private equity firms in Central and Eastern Europe. Active since 1990, the firm has raised ten funds that have invested and committed EUR 2.3 billion in 156 companies and exited 140 companies.
Affidea Group is a pan-European diagnostic imaging and community-based polyclinic and specialist healthcare services provider, including cancer care. Founded in 1991, the company operates 366 centres across 15 countries, providing high-quality medical services to nearly 14 million patients every year. Affidea is majority-owned by Groupe Bruxelles Lambert (GBL), a leading investment holding company, focused on long-term value-creation with a stable and supportive family shareholder base.
NU-MED Group operates four highly specialised medical centres, located in Elbląg, Katowice, Zamość and Tomaszów Mazowiecki, for the diagnosis and treatment of patients with cancer.
